Prioritis, an IQVIA business is a global provider in market access solutions for pharmaceutical, biotechnology and medical devices.
With strategic HTA, pricing and reimbursement capabilities, Prioritis advises its clients at all stages of a product development and commercialization. Its expertise covers France and top European and international pharmaceutical markets.
Prioritis’ global platforms, Prismaccess/Evalumade and PrismHEOR, deliver a unique integrated service on HTA, reimbursement and economic insights, supporting decision makers at all stages of their drug’s life.